<DOC>
	<DOCNO>NCT02667470</DOCNO>
	<brief_summary>The objective study evaluate change Overactive Bladder ( OAB ) Symptom Score ( OABSS ) score Solifenacin treatment OAB patient evaluate correlation change OABSS score measure OAB symptom .</brief_summary>
	<brief_title>Reproducibility Study OABSS Its Response Treatment</brief_title>
	<detailed_description />
	<mesh_term>Urinary Bladder , Overactive</mesh_term>
	<mesh_term>Solifenacin Succinate</mesh_term>
	<criteria>At screen visit ( Week 2 ) : Symptoms OAB ≥ 3 month Number urgency episode last 3 day ≥ 3 Based 3day micturition diary prior Visit 1 ( Week 0 ) : Number micturition per day ≥ 8 Number urgency episodes 3 day ≥ 3 At screen visit ( Week 2 ) : Stress predominant factor determine investigator Indwelling catheter practice intermittent selfcatheterization Symptomatic urinary tract infection , chronic inflammation Treatment OAB start , quit change 4 week Diabetic neuropathy At Visit 1 ( Week 0 ) : Patient complete 3day micturition diary accord instruction</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Solifenacin</keyword>
	<keyword>Overactive bladder</keyword>
</DOC>